Health
Take-at-home COVID drug molnupiravir may be on its way — but vaccination is still our first line of defence – The Conversation AU
Merck announced preliminary data suggesting the drug reduced the risk of hospitalisation and death by 50%.
The Australian government has pre-purchased 300,000 courses of an experimental antiviral oral drug called molnupiravir.
Interim results announced by the company, US pharmaceutical Merck, show the drug halved the number of patients who ended up in hospital…
Continue Reading
-
Noosa News13 hours agoMan dies in Brisbane crash, women and girl rushed to hospital
-
General22 hours agoProductivity summit ends day two with progress on rules changes to boost housing supply
-
Noosa News19 hours agoChilling new details emerge in terrifying childcare centre incident in Peregian Springs on the Sunshine Coast
-
Business9 hours agoWhere next for the CBA share price?